Alchem fined almost EUR500,000 in EU for role in pharma cartel
MLex Summary: Alchem has been fined 489,000 euros (around $576,000) for behavior over more than 12 years that included fixing the minimum sales price for pharmaceutical ingredient N-Butylbromide Scopolamine/Hyoscine — known...To view the full article, register now.
Already a subscriber? Click here to view full article